Fiche du document
23 juillet 2020
- doi: 10.58079/phf3
Ce document est lié à :
info:eu-repo/semantics/reference/issn/2629-5687
info:eu-repo/semantics/openAccess
Sujets proches
Drug trade Drug industryCiter ce document
Markus Pohlmann, « Medical ghostwriting, scientific fraud and the "ghost marketing" of the pharmaceutical industry », Corporate Crime Stories, ID : 10.58079/phf3
Métriques
Partage / Export
Résumé
by Markus Pohlmann A lot is uncertain in Corona times. Many of us hope nolens volens that new medicines and vaccines will be developed. Thus, the door is wide open for speculation, charlatanism, influence peddling and big money. Reason for that is that the search for new active ingredients doesn’t always rely on scientific independence and the scientific integrity of decision-makers, researchers, and authors. Rather, it also hides manifested economic interests of the pharmaceutical industry ...